Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""FIBRINOLYTIC agents"" wg kryterium: Temat


Tytuł:
Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens.
Autorzy:
Martinez-Sanchez J; Hemostasis and Erythropathology LaboratoryHematopathologyDepartment of Pathology, Centre de Diagnostic Biomedic (CDB), Hospital Clinic de Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Josep Carreras Leukaemia Research Institute (Campus Clinic), Barcelona, Spain.; Barcelona Endothelium Team, Barcelona, Spain.
Castrillo L; Department of Cardiology, ICCV, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Jerez D; Hemostasis and Erythropathology LaboratoryHematopathologyDepartment of Pathology, Centre de Diagnostic Biomedic (CDB), Hospital Clinic de Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Torramade-Moix S; Hemostasis and Erythropathology LaboratoryHematopathologyDepartment of Pathology, Centre de Diagnostic Biomedic (CDB), Hospital Clinic de Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Palomo M; Hemostasis and Erythropathology LaboratoryHematopathologyDepartment of Pathology, Centre de Diagnostic Biomedic (CDB), Hospital Clinic de Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Barcelona Endothelium Team, Barcelona, Spain.; Hematology External Quality Assessment Laboratory, CDB, Hospital Clinic de Barcelona, Barcelona, Spain.
Mendieta G; Department of Cardiology, ICCV, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain.
Zafar MU; Department of Medicine, AtheroThrombosis Research Unit (ATRU), Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Moreno-Castaño AB; Hemostasis and Erythropathology LaboratoryHematopathologyDepartment of Pathology, Centre de Diagnostic Biomedic (CDB), Hospital Clinic de Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Barcelona Endothelium Team, Barcelona, Spain.
Sanchez P; Department of Marine Biology and Oceanography, Institut de Ciències del Mar, Spanish National Research Council, Barcelona, Spain.
Badimon JJ; Department of Medicine, AtheroThrombosis Research Unit (ATRU), Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Diaz-Ricart M; Hemostasis and Erythropathology LaboratoryHematopathologyDepartment of Pathology, Centre de Diagnostic Biomedic (CDB), Hospital Clinic de Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Barcelona Endothelium Team, Barcelona, Spain.
Escolar G; Hemostasis and Erythropathology LaboratoryHematopathologyDepartment of Pathology, Centre de Diagnostic Biomedic (CDB), Hospital Clinic de Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Barcelona Endothelium Team, Barcelona, Spain.
Roqué M; Department of Cardiology, ICCV, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 27; Vol. 13 (1), pp. 22969. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Fibrinolytic Agents*/pharmacology
Thrombin*/pharmacology
Humans ; Aspirin/pharmacology ; Blood Platelets ; Fibrin/pharmacology ; Platelet Aggregation Inhibitors/pharmacology
Czasopismo naukowe
Tytuł:
Postoperative bleeding after percutaneous transhepatic gallbladder drainage and aspiration in patients receiving antithrombotic therapy.
Autorzy:
Iwamoto T; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Suda T; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Inoue T; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Nozaki Y; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Mizumoto R; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Arimoto Y; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Ohta T; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Yamaguchi S; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Ito Y; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Hagiwara H; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Hyogo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 18; Vol. 18 (8), pp. e0288463. Date of Electronic Publication: 2023 Aug 18 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Fibrinolytic Agents*/adverse effects
Cholecystitis, Acute*
Humans ; Retrospective Studies ; Postoperative Hemorrhage/etiology ; Drainage
Czasopismo naukowe
Tytuł:
Ex Vivo Antiplatelet and Thrombolytic Activity of Bioactive Fractions from the New-Fangled Stem Buds of Ficus religiosa L. with Simultaneous GC-MS Examination.
Autorzy:
Kumar S; Department of Pharmacognosy, Faculty of Pharmacy, Integral University, Kursi-Road, Lucknow 226026, Uttar Pradesh, India.
Arif M; Department of Pharmacognosy, Faculty of Pharmacy, Integral University, Kursi-Road, Lucknow 226026, Uttar Pradesh, India.
Kamal M; Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al- Kharj 11942, Saudi Arabia.
Jawaid T; Department of Pharmacology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia.
Khan MM; Department of Basic Medical Science, College of Medicine, Dar Al Uloom University, Riyadh 13314, Saudi Arabia.
Mukhtar B; Department of Basic Medical Science, College of Medicine, Dar Al Uloom University, Riyadh 13314, Saudi Arabia.; Department of Physiology, Santosh Deemed to be University, Ghaziabad 201009, Uttar Pradesh, India.
Khan A; Faculty of Pharmacy, Quest International University, Ipoh 30250, Malaysia.
Ahmed S; Department of Physiology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia.
AlSanad SM; Department of Pharmacology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia.
Al-Khamees OA; Department of Pharmacology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 May 05; Vol. 28 (9). Date of Electronic Publication: 2023 May 05.
Typ publikacji:
Journal Article
MeSH Terms:
Fibrinolytic Agents*/pharmacology
Fibrinolytic Agents*/therapeutic use
Ficus*
Plant Extracts/pharmacology ; Plant Extracts/therapeutic use ; Methanol ; Antioxidants/pharmacology ; Chloroform ; Gas Chromatography-Mass Spectrometry
Czasopismo naukowe
Tytuł:
The Role of Subretinal Injection in Ophthalmic Surgery: Therapeutic Agent Delivery and Other Indications.
Autorzy:
Tripepi D; Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Italy.
Jalil A; Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WL, UK.
Ally N; Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WL, UK.
Buzzi M; Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Italy.
Moussa G; Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WL, UK.; Lancashire Teaching Hospitals NHS Foundation Trust, Preston PR2 9HT, UK.
Rothschild PR; Department of Ophthalmology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France.; Centre de Recherche des Cordeliers, INSERM, UMR_1138, Université Paris Cité, 75270 Paris, France.
Rossi T; IRCCS Fondazione Bietti-ONLUS, 00184 Rome, Italy.
Ferrara M; Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WL, UK.; Faculty of Medicine, University of Malaga, 29016 Malaga, Spain.
Romano MR; Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Italy.; Eye Center, Humanitas Gavazzeni-Castelli, 24128 Bergamo, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 23; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Tissue Plasminogen Activator*/therapeutic use
Fibrinolytic Agents*/therapeutic use
Vitrectomy/methods ; Visual Acuity ; Tomography, Optical Coherence ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages.
Autorzy:
Boral SK; Department of Vitreoretina, Disha Eye Hospitals Pvt Ltd, Kolkata, West Bengal, India.
Agarwal D; Department of Vitreoretina, Siliguri Greater Lions Eye Hospital, Siliguri, West Bengal, India.
Das A; Department of Vitreoretina, Disha Eye Hospitals Pvt Ltd, Kolkata, West Bengal, India.
Chakraborty D; Department of Vitreoretina, Disha Eye Hospitals Pvt Ltd, Kolkata, West Bengal, India.
Mandal S; Department of Vitreoretina, Disha Eye Hospitals Pvt Ltd, Kolkata, West Bengal, India.
Pokaż więcej
Źródło:
Indian journal of ophthalmology [Indian J Ophthalmol] 2023 May; Vol. 71 (5), pp. 2045-2052.
Typ publikacji:
Journal Article
MeSH Terms:
Tissue Plasminogen Activator*
Fibrinolytic Agents*/therapeutic use
Humans ; Retrospective Studies ; Treatment Outcome ; Retinal Hemorrhage/diagnosis ; Retinal Hemorrhage/etiology ; Retinal Hemorrhage/surgery ; Vitrectomy/methods
Czasopismo naukowe
Tytuł:
A Prospective Observational Study on Gastric Endoscopic Submucosal Dissection under Continuous Administration of Antithrombotic Agents.
Autorzy:
Kawai, Daisuke (AUTHOR)
Iwamuro, Masaya (AUTHOR)
Takenaka, Ryuta (AUTHOR)
Obata, Taisuke (AUTHOR)
Yamamoto, Takashi (AUTHOR)
Hirata, Shoichiro (AUTHOR)
Miura, Ko (AUTHOR)
Takemoto, Koji (AUTHOR)
Tsugeno, Hirofumi (AUTHOR)
Fujiki, Shigeatsu (AUTHOR)
Pokaż więcej
Źródło:
Journal of Clinical Medicine. Apr2024, Vol. 13 Issue 7, p1886. 10p.
Czasopismo naukowe
Tytuł:
International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy.
Autorzy:
Seung Joo Kang
Chung Hyun Tae
Chang Seok Bang
Cheol Min Shin
Young-Hoon Jeong
Miyoung Choi
Joo Ha Hwang
Yutaka Saito
Wai Yan Chiu, Philip
Rungsun Rerknimitr
Khor, Christopher
Vu Van Khien
Kee Don Choi
Ki-Nam Shim
Geun Am Song
Oh Young Lee
Pokaż więcej
Źródło:
Clinical Endoscopy. Mar2024, Vol. 57 Issue 2, p141-157. 17p.
Czasopismo naukowe
Tytuł:
Comparative Analysis of Antithrombotic Therapy Outcomes in Mild Traumatic Brain-Injury Patients: A Focus on Bleeding Risk and Hospital-Stay Duration.
Autorzy:
Desai, Antonio (AUTHOR)
Shiffer, Dana (AUTHOR)
Giordano, Mauro (AUTHOR)
Giotta Lucifero, Alice (AUTHOR)
Generali, Elena (AUTHOR)
Reggiani, Francesco (AUTHOR)
Calatroni, Marta (AUTHOR)
Savioli, Gabriele (AUTHOR)
Luzzi, Sabino (AUTHOR)
Voza, Antonio (AUTHOR)
Pokaż więcej
Źródło:
Life (2075-1729). Mar2024, Vol. 14 Issue 3, p308. 11p.
Czasopismo naukowe
Tytuł:
The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study.
Autorzy:
Tsai CT; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan.; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chan YH; The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Microscopy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
Liao JN; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan.; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chen TJ; Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool & Liverpool Heart and Chest Hospital, Liverpool, UK.; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Chen SA; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.
Chao TF; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan. .; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 13; Vol. 22 (1), pp. 113. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Stroke*/complications
Atrial Fibrillation*/complications
Brain Ischemia*/drug therapy
Ischemic Stroke*/drug therapy
Humans ; Warfarin/therapeutic use ; Anticoagulants/therapeutic use ; Fibrinolytic Agents/therapeutic use ; Cohort Studies ; Constriction, Pathologic/chemically induced ; Constriction, Pathologic/complications ; Constriction, Pathologic/drug therapy ; Hemorrhage/chemically induced ; Intracranial Hemorrhages/chemically induced ; Intracranial Hemorrhages/complications ; Intracranial Hemorrhages/drug therapy ; Arteries ; Administration, Oral
Czasopismo naukowe
Tytuł:
Perioperative Treatment with Rivaroxaban and Dabigatran on Changes of Coagulation and Platelet Activation Biomarkers following Left Atrial Appendage Closure.
Autorzy:
Yao Y; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Li Y; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jin Q; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Li X; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhang X; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Lv Q; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Pokaż więcej
Źródło:
Cardiovascular therapeutics [Cardiovasc Ther] 2024 Mar 12; Vol. 2024, pp. 4405152. Date of Electronic Publication: 2024 Mar 12 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Atrial Appendage*
Stroke*/prevention & control
Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/complications
Thrombosis*
Humans ; Rivaroxaban/adverse effects ; Anticoagulants/adverse effects ; Dabigatran/adverse effects ; Left Atrial Appendage Closure ; Administration, Oral ; von Willebrand Factor/pharmacology ; von Willebrand Factor/therapeutic use ; Fibrinolytic Agents/therapeutic use ; CD40 Ligand/pharmacology ; CD40 Ligand/therapeutic use ; Treatment Outcome ; Platelet Activation ; Biomarkers ; Selectins/pharmacology ; Selectins/therapeutic use
Czasopismo naukowe
Tytuł:
Predictors of the unfavorable outcomes in acute ischemic stroke patients treated with alteplase, a multi-center randomized trial.
Autorzy:
Zeinhom MG; Neurology Department, Faculty of Medicine, Kafr El-Sheikh University, Elgeish Street, Kafr El-Sheikh, Egypt. mohamed_.
Khalil MFE; Neurology Department, Saudi German Hospital Madinah, Abyar Ali. Al Jamaat Rd., Madinah, Saudi Arabia.
Kamel IFM; Neurology Department, Faculty of Medicine, Tanta University, El-gash St., Tanta, Egypt.
Kohail AM; Neurology Department, Faculty of Medicine, Al-Azhar University, ELmokhaim St., Cairo, Egypt.
Ahmed SR; Neurology Department, Faculty of Medicine, Kafr El-Sheikh University, Elgeish Street, Kafr El-Sheikh, Egypt.
Elbassiouny A; Neurology Department, Faculty of Medicine, Ain Shams University, ELabbasia St., Cairo, Egypt.
Shuaib A; Division of Neurology, Department of Medicine, University of Alberta, Clinical Sciences Building, Edmonton, AB, T6G 2R3, Canada.
Al-Nozha OM; Medicine Department, College of Medicine, Taibah University, Janadah Bin Umayyah Rd., Tayba, Madinah, Saudi Arabia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 12; Vol. 14 (1), pp. 5960. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Ischemic Stroke*/drug therapy
Brain Ischemia*/drug therapy
Stroke*/complications
Hyperglycemia*/complications
Adult ; Humans ; Tissue Plasminogen Activator/therapeutic use ; Fibrinolytic Agents/therapeutic use ; Treatment Outcome ; Cerebral Hemorrhage/complications
Czasopismo naukowe
Tytuł:
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.
Autorzy:
Ruigómez A; Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain.
Schink T; Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Voss A; Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
Smits E; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
Swart-Polinder K; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
Balabanova Y; Bayer AG, Berlin, Germany.
Brobert G; Bayer AB, Stockholm, Sweden.
Suzart-Woischnik K; Bayer AG, Berlin, Germany.
García Rodríguez LA; Spanish Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0298596. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Venous Thromboembolism*/drug therapy
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/prevention & control
Atrial Fibrillation*/drug therapy
Humans ; Middle Aged ; Rivaroxaban/adverse effects ; Anticoagulants/therapeutic use ; Gastrointestinal Hemorrhage/chemically induced ; Fibrinolytic Agents/therapeutic use ; Vitamin K ; Factor Xa Inhibitors/adverse effects
Czasopismo naukowe
Tytuł:
Stroke mimics: A case report of cervical spondylosis with intravenous thrombolysis.
Autorzy:
Wang Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Qu H; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Du W; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Wang Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.; Chinese Institute for Brain Research, Beijing, China.; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14434. Date of Electronic Publication: 2023 Aug 31.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Stroke*/diagnostic imaging
Stroke*/drug therapy
Spondylosis*/diagnostic imaging
Spondylosis*/drug therapy
Humans ; Fibrinolytic Agents/therapeutic use ; Administration, Intravenous ; Thrombolytic Therapy
Raport
Tytuł:
Can the combination of antiplatelet or alteplase thrombolytic therapy with argatroban benefit patients suffering from acute stroke? a systematic review, meta-analysis, and meta-regression.
Autorzy:
Xie H; Department of Clinical Pharmacy, The Third Hospital of Quzhou, Quzhou, Zhejiang, 324003, China.
Chen Y; Hangzhou Fuyang District Hospital of Traditional Chinese Medicine, Zhejiang, 311499, China.
Ge W; Department of Clinical Pharmacy, Ninghai First Hospital, Zhejiang, 315600, China.
Xu X; Department of Emergency Internal Medicine, The Third Hospital of Quzhou, Quzhou, Zhejiang, 324003,China.
Liu C; Department of General Medicine, Affiliated Anqing First People's Hospital of Anhui Medical University, HeFei, 246000, China.
Lan Z; Department of Psychiatry Department, The Third Hospital of Quzhou, Quzhou, Zhejiang, 324003, China.
Yang Y; Department of Neurology, Ninghai First Hospital, Zhejiang, 315600, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 27; Vol. 19 (2), pp. e0298226. Date of Electronic Publication: 2024 Feb 27 (Print Publication: 2024).
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Platelet Aggregation Inhibitors*/therapeutic use
Stroke*/complications
Stroke*/drug therapy
Stroke*/chemically induced
Pipecolic Acids*
Sulfonamides*
Arginine/*analogs & derivatives
Humans ; Tissue Plasminogen Activator/therapeutic use ; Retrospective Studies ; Hemorrhage/drug therapy ; Hemorrhage/chemically induced ; Fibrinolytic Agents/therapeutic use ; Thrombolytic Therapy ; Treatment Outcome ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Geographic differences in pharmacotherapy patterns and outcomes of acute ischemic stroke in China.
Autorzy:
Li Y; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Ou Q; Department of medical affairs, Techpool Bio-Pharma Co., LTD, Guangzhou, China.
Lu Y; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Shen Z; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Li J; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Zhang Z; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Tai L; Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, China.
Li G; Department of Neurology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Chen H; Department of Neurology, General Hospital of Shenyang Military Command, Shenyang, China.
Zhang G; Department of Neurology, Penglai People's Hospital, Penglai, China.
Zhang L; Department of Neurology, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Sun X; Department of Neurology, Qindao University Medical College Affiliated Yantai Yuhuangding Hospital, Yantai, China.
Qiu J; Department of Neurology, Huizhou First Hospital, Huizhou, China.
Wei Y; Department of Neurology, Harrison International Peace Hospital, Hengshui, China.
Zhu S; Department of Biostatistics, Peking University First Hospital, Beijing, China.
Wang Z; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China.
Sun W; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China. .; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China. .
Huang Y; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China. .; Beijing Key Laboratory of Neurovascular disease discovery, Beijing, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Feb 15; Vol. 24 (1), pp. 64. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Brain Ischemia*/drug therapy
Brain Ischemia*/epidemiology
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Ischemic Stroke*/drug therapy
Stroke*/drug therapy
Stroke*/epidemiology
Humans ; Fibrinolytic Agents/therapeutic use ; Platelet Aggregation Inhibitors/therapeutic use ; Thrombolytic Therapy ; Treatment Outcome ; Prospective Studies
Czasopismo naukowe
Tytuł:
The safety and efficacy of intra-arterial low-dose tirofiban administration during endovascular therapy in patients with large ischemic core volume.
Autorzy:
Cho KC; Department of Neurosurgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
Son NH; Department of Statistics, Keimyung University, Daegu, South Korea.
Gwon SH; Department of Statistics, Keimyung University, Daegu, South Korea.
Choi JW; Department of Radiology, Ajou University Hospital, Ajou University College of Medicine, 164, World Cup-Ro, Yeongtong-Gu, Suwon, 16499, South Korea.
Jung WS; Department of Radiology, Ajou University Hospital, Ajou University College of Medicine, 164, World Cup-Ro, Yeongtong-Gu, Suwon, 16499, South Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3353. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Ischemic Stroke*/etiology
Brain Ischemia*/drug therapy
Stroke*/therapy
Endovascular Procedures*/adverse effects
Humans ; Tirofiban ; Fibrinolytic Agents/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Hypolipidemic and Antithrombotic Effect of 6'- O -Caffeoylarbutin from Vaccinium dunalianum Based on Zebrafish Model, Network Pharmacology, and Molecular Docking.
Autorzy:
Wu B; Key Laboratory of Forest Resources Conservation and Utilization in the Southwest Mountains of China Ministry of Education, Southwest Forestry University, Kunming 650224, China.; Key Laboratory of State Forestry and Grassland Administration on Highly-Efficient Utilization of Forestry Biomass Resources in Southwest China, Southwest Forestry University, Kunming 650224, China.
Li C; Key Laboratory of Forest Resources Conservation and Utilization in the Southwest Mountains of China Ministry of Education, Southwest Forestry University, Kunming 650224, China.; Key Laboratory of State Forestry and Grassland Administration on Highly-Efficient Utilization of Forestry Biomass Resources in Southwest China, Southwest Forestry University, Kunming 650224, China.
Kan H; Key Laboratory of Forest Resources Conservation and Utilization in the Southwest Mountains of China Ministry of Education, Southwest Forestry University, Kunming 650224, China.
Zhang Y; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650224, China.
Rao X; Academy of Advanced Carbon Conversion Technology, Huaqiao University, Xiamen 361021, China.
Liu Y; Key Laboratory of Forest Resources Conservation and Utilization in the Southwest Mountains of China Ministry of Education, Southwest Forestry University, Kunming 650224, China.; Key Laboratory of State Forestry and Grassland Administration on Highly-Efficient Utilization of Forestry Biomass Resources in Southwest China, Southwest Forestry University, Kunming 650224, China.
Zhao P; Key Laboratory of Forest Resources Conservation and Utilization in the Southwest Mountains of China Ministry of Education, Southwest Forestry University, Kunming 650224, China.; Key Laboratory of State Forestry and Grassland Administration on Highly-Efficient Utilization of Forestry Biomass Resources in Southwest China, Southwest Forestry University, Kunming 650224, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Feb 08; Vol. 29 (4). Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Arbutin*/analogs & derivatives
Caffeic Acids*
Drugs, Chinese Herbal*
Hyperlipidemias*/drug therapy
Thrombosis*/drug therapy
Animals ; Fibrinolytic Agents/pharmacology ; Molecular Docking Simulation ; Network Pharmacology ; Zebrafish
Czasopismo naukowe
Tytuł:
Intravenous thrombolysis in acute ischemic stroke patients with pre-stroke disability: A systematic review and meta-analysis.
Autorzy:
Bao Q; Department of Neurosurgery, Guang'an People's Hospital, Guang'an, Sichuan, China.
Wu X; Department of Anesthesia, Guang'an People's Hospital, Guang'an, Sichuan, China.
Li Y; Graduate School, Qinghai University, Xining, Qinghai, China.
Chen S; Graduate School, Qinghai University, Xining, Qinghai, China.
Zhang Q; Department of Neurosurgery, Qinghai Provincial People's Hospital, Xining, Qinghai, China.
Yang M; Department of Neurosurgery, Qinghai Provincial People's Hospital, Xining, Qinghai, China.
Yang P; Department of Neurosurgery, Qinghai Provincial People's Hospital, Xining, Qinghai, China.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2024 Feb; Vol. 14 (2), pp. e3431.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Ischemic Stroke*/drug therapy
Ischemic Stroke*/complications
Brain Ischemia*/complications
Brain Ischemia*/drug therapy
Stroke*/complications
Stroke*/drug therapy
Humans ; Fibrinolytic Agents/therapeutic use ; Thrombolytic Therapy/adverse effects ; Treatment Outcome ; Cerebral Hemorrhage/complications
Czasopismo naukowe
Tytuł:
Supra-Blan 2 t score as a multisystem-based risk score to predict poor 3-month outcome in acute ischemic stroke patients with intravenous thrombolysis.
Autorzy:
Jin H; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Peng Q; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li M; Department of Neurology, The Second People's Hospital of China Three Gorges University, Yichang, China.
Sun S; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhou J; Department of Neurology, The First Clinical Medical College of China Three Gorges University, Yichang, China.
Hu J; Department of Neurology, People's Hospital of Dongxihu District, Wuhan, China.
Huang M; Department of Neurology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, China.
Chen X; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li Y; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhou Y; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wan Y; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hong C; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen S; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hu B; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Feb; Vol. 30 (2), pp. e14381. Date of Electronic Publication: 2023 Jul 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Stroke*/diagnostic imaging
Stroke*/drug therapy
Ischemic Stroke*/diagnostic imaging
Ischemic Stroke*/drug therapy
Brain Ischemia*/diagnostic imaging
Brain Ischemia*/drug therapy
Humans ; Retrospective Studies ; Risk Factors ; Thrombolytic Therapy ; Treatment Outcome ; Fibrinolytic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Intra-operative blood transfusion in elderly patients on antithrombotic therapy.
Autorzy:
Hjelmdal C; Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Copenhagen, Denmark.
Draegert C; Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Copenhagen, Denmark.
Vester-Andersen M; Department of Anesthesiology, Copenhagen University Hospital, Herlev-Gentofte Hospital, Herlev, Denmark.; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
Kowark A; Department of Anaesthesia, University Hospital RWTH, Aachen, Germany.; Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Coburn M; Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Rasmussen LS; Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
Lundstrøm LH; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.; Department of Anaesthesia, Nordsjaellands Hospital, Hillerød, Denmark.
Steinmetz J; Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.; Danish Air Ambulance, Aarhus, Denmark.
Pokaż więcej
Corporate Authors:
POSE-Study Group
Źródło:
Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2023 Apr; Vol. 67 (4), pp. 412-421. Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Fibrinolytic Agents*/therapeutic use
Neoplasms*
Aged ; Humans ; Aged, 80 and over ; Prospective Studies ; Blood Transfusion ; Blood Loss, Surgical
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies